(Q43083728)

13 November 2017

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States (English)

1 reference

13 November 2017

United States of America

0 references

1 reference

15

1 reference

13 November 2017

14

Arul M Chinnaiyan

1 reference

13 November 2017

Juan-Miguel Mosquera

1

1 reference

13 November 2017

Rohit Mehra

2

1 reference

13 November 2017

Meredith M Regan

3

1 reference

13 November 2017

Sven Perner

4

1 reference

13 November 2017

Elizabeth M Genega

5

1 reference

13 November 2017

Gerri Bueti

6

1 reference

13 November 2017

Rajal B Shah

7

1 reference

13 November 2017

Sandra Gaston

8

1 reference

13 November 2017

Scott A Tomlins

9

1 reference

13 November 2017

John T Wei

10

1 reference

13 November 2017

Michael C Kearney

11

1 reference

13 November 2017

Laura A Johnson

12

1 reference

13 November 2017

Jeffrey M Tang

13

1 reference

13 November 2017

Martin G Sanda

16

1 reference

13 November 2017

language of work or name

English

0 references

publication date

7 July 2009

1 reference

13 November 2017

Clinical Cancer Research

1 reference

13 November 2017

15

1 reference

13 November 2017

14

1 reference

13 November 2017

4706-4711

1 reference

Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3717524

10.1158/1078-0432.CCR-08-2927

1 December 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

19584163

1 reference